QOL-58. IMPROVEMENT IN VISUAL ACUITY OF PEDIATRIC PATIENTS WITH BRAIN TUMORS WITH BEVACIZUMAB

BACKGROUND: Bevacizumab, a monoclonal antibody that targets vascular endothelial growth factor, has been shown in a small series of children with vision loss associated with optic pathway gliomas (OPG) to produce marked vision recovery. METHODS: A single-institution retrospective record review of pe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: McEvoy, Matthew, Hemenway, Molly, Raybin, Jennifer, Green, Adam, Nellan, Anandani, Levy, Jean Mulcahy, Vibhakar, Rajeev, Foreman, Nicholas, McCourt, Emily, Dorris, Kathleen
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012326/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.639
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi